[ET Net News Agency, 5 December 2025] HANSOH PHARMA (03692) rose 3.1% to HK$41.7.
It hits an intra-day high of HK$41.72, hitting a 52-week high, and an intra-day low of
HK$39.94. The total shares traded was 4.37 million, with a value of HK$178.73m. The active
buy/sell ratio is 56:44, with net buying turnover of HK$21.21m. CHINA INNOVATION MARKET
SER accounts for greatest net responsive buying turnover of HK$12.92m, with volume
weighted average price of HK$41.215. MORGAN STANLEY HK SEC accounts for greatest net
responsive selling turnover of HK$10.22m, with volume weighted average price of HK$40.857.
The stock has risen a combined 3.8% over the past 2 consecutive trading days.
The Hang Seng Index now rose 157 points, or 0.6% to 26,093.

Basic Information
=================

----------------------------------
Nominal 41.700 % Chg +3.06%
High 41.720 Low 39.940
Shares Tr 4.37m Turnover 178.73m
10-D SMA 40.530 %H.V 31.940
20-D SMA 39.413 VWAP 40.876
50-D SMA 37.377 RSI14 66.796
----------------------------------
Status: Hitting a 52-week high, active buy/sell ratio is 56:44, with net buying turnover
of HK$21.21m, rising a combined 3.8% over the past 2 consecutive trading days

Performance of stocks in the same sector or of relevance
========================================================

Stock (Code) Price (HK$) Change (%)
-----------------------------------------------
HANSOH PHARMA (03692) 41.70 +3.06
CSPC PHARMA (01093) 7.64 -0.13
SINO BIOPHARM (01177) 6.81 -1.02
HENGRUI PHARMA (01276) 73.70 +1.10
INNOVENT BIO (01801) 92.10 -1.55
WUXI BIO (02269) 32.72 -0.67
WUXI APPTEC (02359) 103.00 +0.29
SH PHARMA (02607) 12.13 +0.50
BEONE MEDICINES (06160) 198.30 -1.05
AKESO (09926) 123.40 Unchanged
-----------------------------------------------
(ed)